Results Speak Louder: Fitterfly's Youthful Diabetes Success and Collab with Healthcare Stakeholders!

Results Speak Louder: Fitterfly's Youthful Diabetes Success and Collab with Healthcare Stakeholders!

At Fitterfly, we commemorated both Diabetes and Children’s Day on the 14th of November by highlighting the fact that Diabetes now catches them young and there is an urgent need to raise awareness among parents and children about it. Just a few years back, Type 2 Diabetes was considered a condition of the elderly. However, our insights from 16,000 interactions with people who used the Fitterfly Diabetes Reversal Calculator showed that 60% of people with Diabetes were under 45 years of age - the most important population for India’s growth story.

While we manage Diabetes for people of all ages, we’re proudest to showcase the outcomes for our VVIPs - children with Type 2 Diabetes. It’s heartwarming to share that 7 children who finished the Diabetes program by Fitterfly - all 100% showed substantial reduction in HbA1c and medicines.  

However, we know that Fitterfly cannot solve the Diabetes problem alone. We need other healthcare stakeholders to join forces. We witnessed the pharma industry and clinicians take active steps to reduce the Diabetes burden in India.  

OPPI, an organization of MNC pharma companies, is now working with the slogan #bharatkeliye to help the India@100 mission. It was heartening to see the Organisation of Pharmaceutical Producers of India (OPPI ) waking up to the possibilities afforded by digital therapies. We were invited to talk about how pharma can work with health-tech companies, how patients can become more participative in their care, and how the outcomes and efficiency of healthcare systems can improve. 

Involving clinicians in building technology-driven lifestyle management as the first line of therapy for Diabetes and obesity has been a mission for us. So, it was great that Fitterfly was selected to have a significant presence at the annual meeting of the Research Society for Study in Diabetes in India (RSSDI), the largest think tank of doctors treating Diabetes in India. More than 5000 doctors registered for the event. Our presentations included:

  1. Keynote lecture in BB Tripathi Research Symposium: How Personalised Glycemic Response (PGR) score-based programs can help people in early stages achieve Diabetes remission.

  2. Poster presentation: Personalised Glycemic Response based Fitterfly Diabetes CGM program improved dietary choices, glycemic control, and weight among people with poorly controlled Diabetes.

  3. Poster presentation: Real-world outcomes of Fitterfly Diabetes program on glycemic control and weight management in newly diagnosed type 2 Diabetes.

  4. Dr. Mohan Shenoy showcased technology and outcomes from Fitterfly in his lecture on ‘App Based Coaching’. 

As I conclude this CEO's note, I want to express my deep gratitude for the incredible efforts and collaborations that continue to drive Fitterfly's mission forward. While we remain committed to pushing the boundaries for overall health outcomes and using technology to address the unmet needs of people with Diabetes and their treating doctors, let's also embrace the holiday spirit. With Christmas approaching, may your days be filled with joy and warmth, and here's to a -

Happy New Year in advance!

Thank you for being part of our journey.

Happy Holidays, everyone! 


250➕ Lives Touched @ The Diabetes Awareness Camp, CST station

We celebrated November as Diabetes Awareness Month with our first-ever camp at CST Station in Mumbai, giving free blood sugar checks and counselling. Over 250 passerby's participated, sharing joy and relief, making it a truly heartwarming experience. Watch Now


Young India's Voice Against Diabetes.

14th November, Children's Day which was also World Diabetes Day, we wanted to spread awareness through this cute video on how even our younger ones are not safe from the clutches of Diabetes unless we adults decide to take steps to keep it at bay for ourselves and them. Watch Now


Spreading Knowledge @ The OPPI Summit 2023

At the OPPI Summit 2023, Dr. Singal showed how Digital Therapeutics could revolutionize healthcare in India by 2047 - especially health conditions affecting over 300 million people, like Diabetes, prediabetes, obesity & more. Read More


Proud Presenters @ The RSSDI 2023 Conference

At the RSSDI 2023 Conference, Dr. Singal and Dr. Vineet Nair presented Fitterfly's Diabetes Prime Program's success in improving blood sugar control and weight management in people with Type2 Diabetes - both newly diagnosed and poorly controlled patients. Read More


Say Hello to the Enhanced Fitterfly Diabetes Prime Program 

Fitterfly's marquee product Fitterfly Diabetes Prime Program is now bigger, better, and more focused on achieving higher outcomes. With a more engaging approach and improved user experience, we're taking Diabetes care to the next level. Read Brochure


Is Your Weight Under Control?

Beat Diabetes with the Clinically-proven Fitterfly Diabetes Prime Program. Check Now


Hope you enjoyed this edition of Fitterfly Highs. Wishing you more smiles and a fitter you.

Dr Arbinder Singal & Shailesh Gupta

Need a Sales guy?

Dr Arbinder Singal

Building the future| Diabetes| Obesity| Heart Health| Pediatric Urologist & Entrepreneur| AIIMS Gold Medalist

7mo
Manish Sarvaiya

Business Head, Glenmark Pharmaceuticals Access Ex Entero Healthcare, Piramal Healthcare Abbott India Ltd ; Sun Pharma ; Amul

7mo

Congratulations

To view or add a comment, sign in

Insights from the community

Others also viewed

Explore topics